Teva legal chief exercises options and sells shares

Q: How many TEVA shares did Dov Bergwerk sell, and at what price?

Dov Bergwerk sold 17,505 ordinary shares and 8,755 ordinary shares on November 4, 2026, each at $41.72 per share. No Rule 10b5-1 plan is reported.

Both option exercises were followed by sales of the same share counts at $41.72 per share on November 4, 2026.

Available on EDGAR 11/06/2026 - 04:02 PM EST Accepted by SEC EDGAR 11/06/2026 - 04:01 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Dov Bergwerk, TEVA’s interim chief legal officer, exercised options for 17,505 ordinary shares at $34.70 per share and 8,755 ordinary shares at $28.98 per share on November 4, 2026. He acquired the corresponding shares and sold the same quantities that day, each sale at $41.72 per share. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and Sale: 26,260 shares ($234K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Bergwerk Dov

Role Interim Cheif Legal Officer

Sold 26,260 shs ($1.10M)

Approx. gross sale proceeds $1.10M

Approx. exercise cost $861K

Approx. pre-tax spread $234K

Type	Security	Shares	Price	Value
Exercise	Stock Options (right to buy) ^F1	17,505	$0.00	$0.00
Exercise	Stock Options (right to buy) ^F2	8,755	$0.00	$0.00
Exercise	Ordinary Shares	17,505	$34.70	$607K
Sale	Ordinary Shares	17,505	$41.72	$730K
Exercise	Ordinary Shares	8,755	$28.98	$254K
Sale	Ordinary Shares	8,755	$41.72	$365K

Holdings After Transaction: Stock Options (right to buy) — 0 contracts (Direct); Ordinary Shares — 11,943 shares (Direct)

Footnotes (2)

F1. Stock options were granted on March 3, 2017, with 4,376 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 4,377 having vested on March 3, 2021.
F2. Stock options were granted on May 24, 2017, with 2,188 having vested on each of May 24, 2018, May 24, 2019 and May 24, 2020, and 2,191 having vested on May 24, 2021.

Key Figures

Stock options exercised: 17,505 shares Exercise price: $34.70 per share Stock options exercised: 8,755 shares +3 more

6 metrics

Stock options exercised 17,505 shares November 4, 2026; exercise price $34.70 per share

Exercise price $34.70 per share 17,505 options exercised on November 4, 2026

Stock options exercised 8,755 shares November 4, 2026; exercise price $28.98 per share

Exercise price $28.98 per share 8,755 options exercised on November 4, 2026

Ordinary shares sold 17,505 shares November 4, 2026, at $41.72 per share

Ordinary shares sold 8,755 shares November 4, 2026, at $41.72 per share

Key Terms

Stock Options (right to buy), vested, exercise price, Ordinary Shares

4 terms

Stock Options (right to buy) financial

"Stock Options (right to buy)"

vested financial

"with 4,376 having vested on each of March 3, 2018"

exercise price financial

"options exercised at $34.70 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Ordinary Shares financial

"underlying security: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TEVA shares did Dov Bergwerk sell, and at what price?

Dov Bergwerk sold 17,505 ordinary shares and 8,755 ordinary shares on November 4, 2026, each at $41.72 per share. No Rule 10b5-1 plan is reported.

How did Dov Bergwerk’s TEVA options vest?

The 17,505 options were granted on March 3, 2017, with 4,376 vesting on each March 3, 2018, March 3, 2019, and March 3, 2020, and 4,377 vesting on March 3, 2021. The 8,755 options were granted on May 24, 2017, with 2,188 vesting on each May 24, 2018, May 24, 2019, and May 24, 2020, and 2,191 vesting on May 24, 2021.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bergwerk Dov

(Last)

(First)

(Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 DVORA HA'NEVIA STREET

(Street)

TEL AVIV

6944020

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Interim Cheif Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	11/04/2026		M		17,505	A	$34.7	29,448	D
Ordinary Shares	11/04/2026		S		17,505	D	$41.72	11,943	D
Ordinary Shares	11/04/2026		M		8,755	A	$28.98	20,698	D
Ordinary Shares	11/04/2026		S		8,755	D	$41.72	11,943	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (right to buy)	$34.7	11/04/2026		M			17,505	⁽¹⁾	03/03/2027	Ordinary Shares	17,505	$0	0	D
Stock Options (right to buy)	$28.98	11/04/2026		M			8,755	⁽²⁾	05/24/2027	Ordinary Shares	8,755	$0	0	D

Explanation of Responses:

1. Stock options were granted on March 3, 2017, with 4,376 having vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 4,377 having vested on March 3, 2021.

2. Stock options were granted on May 24, 2017, with 2,188 having vested on each of May 24, 2018, May 24, 2019 and May 24, 2020, and 2,191 having vested on May 24, 2021.

	/s/ Dov Bergwerk	11/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR